Connection

Angelina Passaro to Receptor Protein-Tyrosine Kinases

Back to Details
This is a "connection" page, showing publications Angelina Passaro has written about Receptor Protein-Tyrosine Kinases.
Angelina Passaro
Connection Strength
0.307
Receptor Protein-Tyrosine Kinases
  1. Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. Future Oncol. 2018 Feb; 14(4):353-361.
    View in: PubMed
    Score: 0.155
  2. Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients. Drugs Today (Barc). 2017 Aug; 53(8):435-446.
    View in: PubMed
    Score: 0.152
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.